CLINICAL_TRIALS
trial_result
· 2010-03-02
Clinical Trial Update: Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer [Phase 2]
Summary
A Phase 2 study evaluating BMS-275183 in patients with pre-treated non-small cell lung cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED